Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Promote Oral Films CDMO Services at CPhI North America

SAINT LAURENT, Quebec, April 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its...
April 16, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Files Non-Provisional U.S. Patent Application for Oil-Based Active Ingredients

SAINT LAURENT, Quebec, April 16, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has filed a new...
April 08, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Promote VetaFilm™ Oral Film Technology at Human Biotech & Animal Health Business Partnering Summit

SAINT LAURENT, Quebec, April 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its...
April 04, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Presents at 14th International Conference on Alzheimer’s and Parkinson’s Disease

SAINT LAURENT, Quebec, April 04, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced its two Montelukast poster...
April 02, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA

SAINT LAURENT, Quebec, April 02, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced it has received a Complete...
March 27, 2019 17:01 ET | Source: IntelGenx Technologies Corp.

IntelGenx Grants Stock Options

SAINT LAURENT, Quebec, March 27, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTC.QX:IGXT) announced today that the Company’s board of...
March 22, 2019 16:05 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports Fourth Quarter and Full-Year 2018 Financial Results

SAINT LAURENT, Quebec, March 22, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter...
March 18, 2019 17:35 ET | Source: IntelGenx Technologies Corp.

CORRECTION - IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 22, 2019 – Conference Call to Follow on March 25, 2019

SAINT LAURENT, Quebec, March 18, 2019 (GLOBE NEWSWIRE) -- In a release issued under a similar headline earlier today by IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT), please note that...
March 18, 2019 16:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 25, 2019 – Conference Call to Follow

SAINT LAURENT, Quebec, March 18, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) today announced that it will release its fourth quarter and full year 2018...
February 14, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Montreal’s Douglas Mental Health University Institute as Ninth Montelukast VersaFilm™ Phase 2a Clinical Trial Site

SAINT LAURENT, Quebec, Feb. 14, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that, subject to final research...